|
|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$4,561,541
|
N/A
|
National Institutes of Health
|
|
|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
5R01CA173481-02
|
$378,088
|
$378,088
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Estrogen-ERbeta Axis In Disparity of Prostate Cancer
|
5U01CA149204-04
|
$271,258
|
$271,258
|
ABDEL-MAGEED, ASIM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Role of Oncogenic Kinase Pim-1 in Prostate Cancer
|
7R01CA123484-07
|
$276,202
|
$276,202
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
Prostate Cancer Recurrence: models and mechanisms
|
7R01CA167966-03
|
$351,723
|
$351,723
|
ABDULKADIR, SARKI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
5P50CA094056-14
|
$1,264,315
|
$151,718
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced Costimulation
|
5R01CA109339-10
|
$289,346
|
$289,346
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-04
|
$1,070,836
|
$96,375
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
$58,976
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Regulation of metastases by tumor suppressor INPP4B
|
1R15CA179287-01A1
|
$418,144
|
$418,144
|
AGOULNIK, IRINA
|
FLORIDA INTERNATIONAL UNIVERSITY
|
|
|
Small molecule antagonists of relaxin receptor
|
5U01CA177711-02
|
$288,313
|
$288,313
|
AGOULNIK, ALEXANDER
|
FLORIDA INTERNATIONAL UNIVERSITY
|
|
|
Resveratrol-Zinc Combination for Prostate Cancer
|
5R21CA176867-02
|
$158,759
|
$158,759
|
AHMAD, NIHAL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-04
|
$283,563
|
$283,563
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$529,634
|
$52,963
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
ATBC Study
|
ZIA CP010195 - 03031
|
$1,066,167
|
$245,218
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
SELECT and Prostate Cancer Prevention Trial (PCPT)
|
ZIA CP010221 - 10405
|
$234,370
|
$234,370
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Medical University of South Carolina - Cancer Center Support Grant
|
2P30CA138313-06
|
$1,495,000
|
$254,150
|
ALBERG, ANTHONY
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
1U10CA180790-01
|
$1,439,850
|
$115,188
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
2U54CA143924-06
|
$1,374,976
|
$219,996
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Addressing Prostate Cancer Information Disparities with eHealth Technology
|
5R21CA178296-02
|
$167,844
|
$167,844
|
ALLEN, JENNIFER
|
TUFTS UNIVERSITY BOSTON
|
|
|
Training Program in Cancer Immunobiology
|
5T32CA009598-25
|
$374,589
|
$37,459
|
ALLISON, JAMES
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$276,802
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Control of Apoptosis in Cancer by Survivin
|
2R01CA078810-17
|
$370,000
|
$370,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-45S1
|
$92,630
|
$10,189
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-06
|
$1,197,703
|
$1,197,703
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
1R01CA178610-01A1
|
$320,971
|
$320,971
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
NCTN Deep South Research Consortium
|
1U10CA180855-01
|
$497,800
|
$24,890
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Maryland Prostate Cancer Case-Control Study
|
ZIA BC 010499
|
$363,183
|
$363,183
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$207,533
|
$207,533
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
ZIA BC 010886
|
$51,883
|
$51,883
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$709,489
|
$35,474
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
LTG_Amundadottir
|
ZIA CP010201 - 10569
|
$563,126
|
$168,938
|
Amundadottir, Laufey
|
DCEG (NCI)
|
|
|
Role of a novel class of short RNA, tRFs, in RNA silencing
|
1F31CA189446-01
|
$29,818
|
$29,818
|
ANAYA, JORDAN
|
UNIVERSITY OF VIRGINIA
|
|
|
Angiogenin-induced RNA cleavage in cancer
|
5R01CA168872-02
|
$346,327
|
$173,164
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Predicting Prostate Cancer Aggressiveness
|
5U01CA151924-04
|
$540,144
|
$540,144
|
ANDERSON, ALEXANDER
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
1U10CA180828-01
|
$656,150
|
$32,808
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$505,808
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$3,750
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$6,133
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Characterization of Epigenetic Targets in Prostate Cancer
|
1K99CA187664-01
|
$114,829
|
$114,829
|
ASANGANI, IRFAN
|
UNIVERSITY OF MICHIGAN
|
|
|
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
|
5R01CA140734-04
|
$299,261
|
$299,261
|
AYALA, GUSTAVO
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
|
Linking State Registry and All Payer Claims Data to Study Cancer Care
|
5R21CA172892-02
|
$61,944
|
$15,486
|
AYANIAN, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
|
San Juan Minority-Based Community Clinical Oncology Program
|
3U10CA052667-23S1
|
$98,520
|
$11,822
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
$11,228
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
$18,360
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
$22,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$663,170
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
1R01CA168393-01A1
|
$361,050
|
$361,050
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Androgen Receptor Action in Castration Resistant Prostate Cancer
|
5P01CA163227-02
|
$2,010,837
|
$2,010,837
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Genomic instability and DNA repair in a distinct molecular class of prostate canc
|
1K08CA187417-01
|
$172,908
|
$172,908
|
BARBIERI, CHRISTOPHER
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Total relevant funding to Prostate for this search: $217,811,379
|
